Inactive Instrument

Forest Laboratories, Inc. Share Price

Stocks

End-of-day quote NYSE Other stock markets
- ^USD	-

06/14/06	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/14/06	Actavis : M&A frenzy in healthcare sector	RE

06/14/06	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/14/06	Actavis : M&A frenzy in healthcare sector	RE
14/14/14	Actavis : Investors support deals spree, happy to see U.S. companies buy growth	RE
11/14/11	Icahn backs down from demand that eBay spin off PayPal	RE
21/14/21	Suntory Beverage & Food Ltd : Goldman Sachs misses out on WhatsApp, 2014's top deals so far	RE
19/14/19	Icahn says Actavis-Forest deal validates shareholder activism	RE
19/14/19	Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/14/18	Actavis PLC : Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/14/18	Actavis PLC : Actavis in talks to buy Forest Labs for as much as $25 billion - WSJ	RE
09/14/09	S&P 500 ends flat in wake of Fed minutes	RE
08/14/08	Forest Laboratories, Inc. : Forest Labs to buy Aptalis from TPG for $2.9 billion	RE
08/14/08	Evercore Partners Inc. : Forest Labs nears $3 billion deal for Aptalis - source	RE
24/13/24	Elan Corporation, plc : Exclusive - TPG-backed Aptalis Pharma hires banks for an IPO: sources	RE

01/14/01	Forest Laboratories : Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest	BU
30/14/30	Forest Laboratories : Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results	BU
24/14/24	Forest Laboratories : Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD)	BU
23/14/23	Forest Laboratories : Actavis and Forest Laboratories Announce Appointment of C. David Nicholson, PhD to lead Actavis Global Brands Research and Development	BU
21/14/21	Forest Laboratories : to Present Cariprazine Data at the International College of Neuropsychopharmacology World Congress	BU

17/16/17	Devisen: Euro fällt zum USD weiter - Hinweise auf US-Zinserhöhung belasten
28/14/28	Bank of America : Wall Street ouvre en hausse, les pharmaceutiques en vue
28/14/28	Wall Street ouvre en hausse, les pharmaceutiques en vue
28/14/28	Actavis : Forest Laboratories achète Furiex pour 1,46 milliard de dollars
28/14/28	Forest Laboratories : Pharmacie-Forest achète Furiex pour $1,46 milliard

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+1.97%	+1.43%	+48.44%	+156.66%	1,05700Cr
JOHNSON & JOHNSON	+1.42%	+3.72%	+53.32%	+52.34%	62TCr
ABBVIE INC.	+1.43%	+0.99%	+34.83%	+78.74%	45TCr
ROCHE HOLDING AG	+0.89%	+5.18%	+32.59%	+28.52%	34TCr
NOVARTIS AG	-0.38%	+1.79%	+36.04%	+40.13%	30TCr
ASTRAZENECA PLC	-0.70%	+0.02%	+15.50%	+16.85%	26TCr
NOVO NORDISK A/S	-0.59%	-3.39%	-28.71%	-42.05%	22TCr
AMGEN INC.	+1.49%	-0.02%	+20.14%	+58.21%	20TCr
GILEAD SCIENCES, INC.	+0.40%	-3.99%	+15.23%	+62.28%	16TCr
Average	+0.67%	+0.77%	+25.27%	+50.19%	40.16TCr
Weighted average by Cap.	+1.07%	+1.57%	+35.01%	+75.50%

Employees

Sector